LIVN: Growth momentum continues with innovation, reimbursement, and product upgrades fueling future gains
Sustained growth is driven by talent, execution, and innovation, with strong tailwinds from reimbursement and clinical data in epilepsy and supply chain improvements. Margin expansion will be reinvested in new growth areas like sleep apnea, while ongoing innovation and product upgrades support long…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.